EndoSonics of Rancho Cordova, CA, announced this month an agreement with Jomed of Helsingborg, Sweden, to develop an intravascular ultrasound-guided stent delivery system together. The new system will integrate EndoSonics’ electronic imaging
EndoSonics of Rancho Cordova, CA, announced this month an agreement with Jomed of Helsingborg, Sweden, to develop an intravascular ultrasound-guided stent delivery system together. The new system will integrate EndoSonics electronic imaging catheter with Jomeds stent and balloon devices. The two firms hope their combined product will decrease post-angioplasty complications and streamline interventional procedures. Jomed anticipates marketing the device in early 1999, pending CE Mark approval.
In other EndoSonics news, the company announced that it has agreed to a five-year hiatus in its intellectual property claim litigation with Intravascular Research of the U.K. The temporary truce includes closing a Delaware lawsuit between the companies involving patent infringement disputes.
Stay at the forefront of radiology with the Diagnostic Imaging newsletter, delivering the latest news, clinical insights, and imaging advancements for today’s radiologists.
Key MRI Findings Predictive of Treatment Response for Unresectable Hepatocellular Carcinoma
July 14th 2025For patients with unresectable hepatocellular carcinoma, a pre-treatment MRI finding of LI-RADS tumor in vein was associated with over an 86 percent lower likelihood of responding to transcatheter arterial chemoembolization (TACE) and targeted immunotherapy.